After losing his wife to colon cancer, a New York man dedicates his life to fighting the disease and developing personalized cancer vaccines through his company BreakBio.
Key Points
Roy de Souza lost his wife to colon cancer and founded BreakBio to develop personalized cancer vaccines
BreakBio's therapy uses machine learning to analyze cancer cells and create personalized treatments
The FDA has granted BreakBio approval to start clinical trials for its colorectal therapy
Pros
Development of personalized cancer vaccines through BreakBio
Potential for more effective cancer treatments
Utilizing AI technology to analyze cancer cells and tailor treatments
Cons
Limitations in immune response strength for personalized vaccines
Manufacturing challenges in creating personalized vaccines
Not all patients may be candidates for personalized vaccines